Regenerative medicine approach as an alternative treatment to islet transplantation

Transplantation Proceedings
K SekineH Taniguchi

Abstract

Islet transplantation is considered to be one of the most promising treatment for type I diabetes mellitus (TID). Development of the Edmonton protocol opened the possibility of insulin independence for the patients with TID. However, there is the problem of the donor shortage. Herein we have discussed recent approaches to overcome the problem. It is neccessary to develop a new cellular source for donor islets and to achieve a high engraftment rate. One advantage in TID therapy is that allogeneic islet transplantation is allowed to avoid autoimmunity. That opens broad candidates for the beta-cell source. To achieve a high engraftment rate, is several attempts have sought to develop an appropriate site for transplantation and to modify beta-cells for long-term survival. It is also important to achieve early onset of blood perfusion after transplantation by prevascularization of the islets in vitro. These multiple approaches will bring a milestone in diabetes therapy.

References

Sep 28, 2005·Nature Biotechnology·Michiki NarushimaJi-Won Yoon
Sep 29, 2006·The New England Journal of Medicine·A M James ShapiroJonathan R T Lakey
Aug 30, 2008·Diabetes·Marcela Brissova, Alvin C Powers
Mar 17, 2009·Nature Chemical Biology·Shuibing ChenDouglas Melton
Mar 3, 2011·Cell Stem Cell·Simon R SmuklerDerek van der Kooy
Aug 20, 2011·Genes & Development·Yu-Ping YangChristopher V E Wright
Aug 26, 2011·The Journal of Clinical Investigation·Philippe RavassardRaphael Scharfmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Journal of Hepato-biliary-pancreatic Sciences
Keisuke Sekine, Hideki Taniguchi
Seminars in Cell & Developmental Biology
Gordon C Weir
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Gareth J RogersP E Squires
© 2021 Meta ULC. All rights reserved